David Thomson
General Counsel chez MANNKIND CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
David B.
Thomson has held multiple positions throughout his career.
Currently, he is the Secretary, Executive VP & General Counsel at MannKind Corp.
and also holds the position of Vice President at QrumPharma, Inc. In terms of education, Dr. Thomson completed his undergraduate degree in 1990, followed by a graduate degree in 1991, and a doctorate in 1994 from Queen's University.
He later obtained another graduate degree in 1999 from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MANNKIND CORPORATION
0,18% | 21/03/2024 | 493 482 ( 0,18% ) | 2 M $ | 31/03/2024 |
Postes actifs de David Thomson
| Sociétés | Poste | Début |
|---|---|---|
| MANNKIND CORPORATION | General Counsel | 01/01/2002 |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - |
Formation de David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
